Ken Griffin Cel Sci Corp Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Cel Sci Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 16,600 shares of CVM stock, worth $11,952. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,600
Previous 50,600
67.19%
Holding current value
$11,952
Previous $96,000
80.21%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding CVM
# of Institutions
74Shares Held
6.24MCall Options Held
16.6KPut Options Held
148K-
Vanguard Group Inc Valley Forge, PA2.41MShares$1.74 Million0.0% of portfolio
-
Black Rock Inc. New York, NY775KShares$557,7860.0% of portfolio
-
Geode Capital Management, LLC Boston, MA613KShares$441,2590.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ448KShares$322,3240.0% of portfolio
-
State Street Corp Boston, MA194KShares$139,3250.0% of portfolio
About CEL SCI CORP
- Ticker CVM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,367,500
- Market Cap $31.2M
- Description
- CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...